Ephedrine
Ephedrine is a stimulant medication used to treat dangerously low blood pressure during anesthesia (by injection) and to temporarily relieve mild intermittent asthma symptoms (by tablet).
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 34 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Ephedrine: Patient Information Guide
A plain-language walkthrough of Ephedrine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Ephedrine is available in different forms used for different medical purposes — the right use depends on the specific product, route, and formulation.
- Low blood pressure during anesthesia (hypotension): Ephedrine Sulfate Injection, Akovaz, and Emerphed — all given intravenously — are used by healthcare providers to treat clinically significant drops in blood pressure that occur during anesthesia.
- Mild intermittent asthma symptoms: Bronkaid, Primatene, Ephedrine Hydrochloride tablets, and Ephedrine Sulfate tablets are taken by mouth to temporarily relieve wheezing, chest tightness, and shortness of breath in adults and children 12 and older who have been told by a doctor they have asthma.
⚙️How it works▾
Ephedrine is a sympathomimetic amine — meaning it mimics and boosts the body's own stress-response signals. It works two ways at once: it directly activates alpha- and beta-adrenergic receptors throughout the body, and it triggers the release of norepinephrine from nerve endings. In the heart and blood vessels, this combination increases heart rate, pumping strength, and blood pressure. In the lungs, activation of beta receptors relaxes and opens the airways (bronchodilation), making it easier to breathe.
One important limitation: with repeated doses, the body can become tolerant — a phenomenon called tachyphylaxis — and ephedrine's blood-pressure-raising effect may weaken. This is why injectable ephedrine is carefully dosed and monitored in clinical settings, and why oral tablets are intended only for occasional, mild asthma symptoms.
💊How it's taken▾
How and how often ephedrine is taken depends entirely on the product form. Injectable forms (Akovaz, Emerphed, Ephedrine Sulfate Injection) are given intravenously by trained healthcare providers in clinical settings — dosing is adjusted to achieve a blood pressure goal and is not something patients manage themselves.
- For asthma tablets (Bronkaid, Ephedrine Sulfate): one tablet every 4 hours as needed for adults and children 12 and older; no more than 6 tablets in 24 hours.
- For Ephedrine Hydrochloride and Primatene tablets: one to two tablets every 4 hours as needed; no more than 12 tablets in 24 hours.
Always follow the directions on your specific product label or your prescriber's instructions. Do not use more than the recommended amount.
🤒Side effects — in detail▾
The most commonly reported side effects with ephedrine include:
- Nausea and vomiting
- Fast heart rate (tachycardia)
- Heart palpitations (a pounding or racing feeling in the chest)
- Elevated blood pressure
- Dizziness
- Restlessness
- Difficulty sleeping
- Tremors or nervousness
More serious reactions to watch for include a rapid or irregular heartbeat, seizures, signs of a heart attack or stroke (chest pain, sudden weakness, slurred speech), or blood pressure that rises to a dangerous level. Seek emergency care immediately if any of these occur.
⚠️Warnings & precautions▾
- Heart attack and stroke risk: Ephedrine raises blood pressure and heart rate. Using it — especially at higher doses or more frequently than directed — increases the risk of heart attack or stroke. This risk is higher if you already have heart disease or high blood pressure.
- Risk of high blood pressure when used preventively: Using ephedrine to prevent low blood pressure (rather than treat it) has been linked to a higher chance of developing dangerously elevated blood pressure.
- Dangerous interaction with oxytocic drugs: Combining ephedrine with drugs that stimulate uterine contractions (such as methylergonovine or ergonovine) can cause severe high blood pressure and stroke. Blood pressure must be carefully monitored in anyone who has received both.
- Tachyphylaxis (reduced effectiveness over time): Repeated doses of ephedrine can make it less effective. For injectable use, providers should have an alternative medication ready. For asthma tablets, relying on ephedrine more and more frequently may mean your asthma needs a different, stronger treatment.
- Asthma alert: These oral tablets are for mild, occasional asthma only. If your asthma is not better within 60 minutes, gets worse, or you're having attacks more than twice a week, see a doctor right away.
🔀What it interacts with▾
Ephedrine can interact with several medications and substances, sometimes in serious ways:
- MAOIs (monoamine oxidase inhibitors, used for depression or Parkinson's disease) — can powerfully amplify ephedrine's stimulant effects; do not use together or within 2 weeks of stopping an MAOI.
- Oxytocic drugs (such as methylergonovine or ergonovine, used after childbirth) — combination can cause dangerously high blood pressure and stroke.
- Clonidine, propofol, atropine — these increase ephedrine's blood-pressure-raising effect; blood pressure should be closely monitored.
- Alpha- and beta-blockers, reserpine, quinidine, mephentermine — these reduce ephedrine's effectiveness.
- Cardiac glycosides (such as digitalis) — raises the risk of dangerous heart rhythm problems (arrhythmias).
- Guanethidine — ephedrine may block its blood-pressure-lowering effect.
- Theophylline — using both together may worsen nausea, nervousness, and insomnia.
- Caffeine (in food, drinks, or supplements) — adds to stimulant effects; avoid while using oral ephedrine tablets.
- Other stimulant-containing products (including those with phenylephrine, pseudoephedrine, or ephedrine) — do not combine.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use oral ephedrine tablets unless a doctor has told you that you have asthma.
- Do not use if you are currently taking an MAOI or have taken one within the past 2 weeks.
- Do not use if you have ever had an allergic reaction to ephedrine or any ingredient in the product.
- Tell your doctor if you have heart disease, high blood pressure, diabetes, thyroid disease, seizures, narrow-angle glaucoma, a psychiatric or emotional condition, or difficulty urinating due to an enlarged prostate.
- Tell your doctor if you have ever been hospitalized for asthma, as this may indicate more serious disease.
- Pregnancy: Ephedrine crosses the placenta. While human data have not confirmed major birth defects, newborns may need monitoring for a blood chemistry imbalance (metabolic acidosis). Discuss the risks and benefits with your doctor.
- Breastfeeding: Ephedrine is present in breast milk. The effects on a breastfed infant are not fully known. Talk to your healthcare provider before using.
- Children: Oral tablet forms should not be used in children under 12 (some brands say to ask a doctor first). The safety of injectable ephedrine in children has not been established.
- Older adults: May be more sensitive to side effects; kidney function should be considered, as ephedrine is cleared through the kidneys and reduced function slows its elimination.
- Kidney impairment: Ephedrine and its breakdown product are removed by the kidneys. Reduced kidney function means the drug stays in the body longer and side effects may be more likely.
🚑If you take too much▾
Too much ephedrine — particularly with the injectable forms — can cause blood pressure to rise rapidly to a dangerous level. If an overdose is suspected, blood pressure should be carefully monitored, and a healthcare provider can administer intravenous medications to bring it down if needed. For oral tablet overdose, contact a Poison Control Center immediately or get emergency medical help right away.
📡Pharmacodynamics — effects in the body▾
Ephedrine's main effect on the body is raising blood pressure by increasing the heart's pumping strength, speeding up heart rate, and tightening blood vessels — all at once. It also relaxes the smooth muscle around the airways, which opens them up and makes breathing easier. As a secondary effect, it may increase resistance to urine flow by acting on smooth muscle in the bladder. With repeated use, these effects can diminish as the body adapts — this is called tachyphylaxis.
🔬Pharmacokinetics — how your body processes it▾
After oral use, ephedrine is broken down by the body into a metabolite called norephedrine, though the exact pathway is not fully understood. Both ephedrine and norephedrine are cleared from the body through the urine. The half-life — the time it takes the body to reduce drug levels by half — is about 6 hours after an oral dose. Ephedrine is also known to cross the placental barrier, meaning it can reach a developing baby during pregnancy.
📦How to store it▾
EMERPHED (ephedrine sulfate injection) is a clear, colorless solution available as single-dose vials containing 5 mg/mL ephedrine sulfate, equivalent to 3. Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) . Store in carton until time of use.
📄 Written from Ephedrine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Ephedrine — the kind of thing our pharmacy team would talk through with you at the counter.
I have asthma — can I just pick up ephedrine tablets at the pharmacy without a prescription? ▾
What should I watch out for when taking the asthma tablets? ▾
I take an antidepressant — is it safe to use ephedrine? ▾
I'm pregnant — is it safe to use ephedrine? ▾
I know ephedrine is used in the hospital during surgery — is that the same thing as the asthma tablet? ▾
Can I use ephedrine tablets every day to keep my asthma under control? ▾
Is Ephedrine available over the counter? ▾
When was Ephedrine first available? ▾
Who makes Ephedrine? ▾
💬 Answers drafted from Ephedrine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Ephedrine comes
Ephedrine is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Ephedrine Sulfate Injection is used to treat clinically important low blood pressure (hypotension) occurring during anesthesia
- Akovaz is used to treat clinically important hypotension occurring in the setting of anesthesia
- Emerphed is used to treat clinically important hypotension occurring in the setting of anesthesia
- Administered intravenously (into a vein) by trained healthcare providers only — not for self-administration
- Emerphed is a premixed, ready-to-use formulation — do not dilute prior to use
- Akovaz 50 mg/mL concentration must be diluted before administration; Akovaz prefilled syringe (5 mg/mL) is premixed and should not be diluted
- Ephedrine Sulfate Injection 50 mg/mL must be diluted with normal saline or 5% dextrose in water before use; inspect for particles and discoloration before administering
Tablet
How this form is used
- Bronkaid is used for temporary relief of mild intermittent asthma symptoms: wheezing, chest tightness, and shortness of breath
- Primatene is used for temporary relief of mild intermittent asthma symptoms: wheezing, chest tightness, and shortness of breath
- Ephedrine Hydrochloride tablets are used for temporary relief of mild intermittent asthma symptoms: wheezing, chest tightness, and shortness of breath
- Ephedrine Sulfate tablets are used for temporary relief of mild intermittent asthma symptoms: wheezing, chest tightness, and shortness of breath
- Bronkaid and Ephedrine Sulfate tablets: adults and children 12 and over take 1 tablet every 4 hours as needed; do not take more than 6 tablets in 24 hours
- Ephedrine Hydrochloride and Primatene tablets: adults and children 12 and over take 1–2 tablets every 4 hours as needed; do not take more than 12 tablets in 24 hours
- Bronkaid and Primatene: do not use in children under 12 years of age
- Ephedrine Hydrochloride: for children under 12, ask a doctor before use
Nasal spray
Other oral form
📊 Ephedrine across the U.S. market
How Ephedrine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (12) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Ephedrine is used
A general measure of how commonly Ephedrine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ephedrine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ephedrine prescribed? Of the 1,596 medications we measure, Ephedrine ranks #957 by Medicaid prescriptions — more than 40% of them.
Utilization by Ephedrine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
1 ML ephedrine sulfate 50 MG/ML Injection Most dispensed
Summed across the 14 of 52 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1116294
10 ML ephedrine sulfate 5 MG/ML Injection
Summed across the 2 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2368456
5 ML ephedrine sulfate 5 MG/ML Prefilled Syringe
Summed across the 3 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2586841
10 ML ephedrine sulfate 5 MG/ML Prefilled Syringe
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2631017
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ephedrine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 20 of 70 listed Ephedrine NDCs with Medicaid activity.
🔍 Compare Ephedrine products
A representative set of FDA-listed product records for Ephedrine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 50 mg/mL | Intravenous | Akorn × 3 listings | NDA | View NDC → |
| 50 mg/mL | Intravenous | Amneal Pharmaceuticals LLC × 3 listings | ANDA | View NDC → |
| 50 mg/mL | Intravenous | AuroMedics Pharma LLC | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Avadel Legacy Pharmaceuticals, LLC | NDA | View NDC → |
| 50 mg/mL | Intravenous | Baxter Healthcare Corporation | ANDA | View NDC → |
| 50 mg/mL | Intravenous | BluePoint Laboratories | NDA | Find on DailyMed ↗ |
| 50 mg/mL | Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Civica, Inc. × 4 listings | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Dr. Reddy's Laboratories, Inc. × 3 listings | ANDA | View NDC → |
| 47 mg/10 mL | Intravenous | Dr. Reddy's Laboratories Inc | NDA | View NDC → |
| 50 mg/mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Exela Pharma Sciences, LLC × 2 listings | NDA | View NDC → |
| 50 mg/mL | Intravenous | Exela Pharma Sciences, LLC × 2 listings | NDA | View NDC → |
| 5 mg/mL | Intravenous | Fresenius Kabi USA, LLC × 2 listings | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 50 mg/mL | Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 3 listings | NDA | View NDC → |
| 5 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Lifestar Pharma LLC | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Medical Purchasing Solutions, LLC × 10 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Nexus Pharamaceuticals Inc. | NDA | View NDC → |
| 5 mg/mL | Intravenous | Nexus Pharmaceuticals, LLC × 2 listings | NDA | View NDC → |
| 50 mg/mL | Intravenous | NorthStar Rx LLC × 3 listings | ANDA | View NDC → |
| 50 mg/mL | Intravenous | NorthStar RxLLC | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Par Health USA, LLC × 2 listings | NDA | View NDC → |
| 50 mg/mL | Intravenous | Par Health USA, LLC × 2 listings | NDA | View NDC → |
| 5 mg/mL | Intravenous | Par Pharmaceutical, Inc. × 2 listings | NDA | View NDC → |
| 50 mg/mL | Intravenous | Par Pharmaceutical, Inc. × 4 listings | NDA | View NDC → |
| 500 mg/10 mL | Intravenous | Par Pharmaceutical, Inc. | NDA | View NDC → |
| 50 mg/mL | — | Patheon Manufacturing Services LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 50 mg/mL | Intravenous | ProPharma Distribution | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Remedyrepack Inc. | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Sandoz Inc × 3 listings | ANDA | View NDC → |
| 50 mg/mL | Intravenous | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 4.7 mg/mL | Intravenous | XGen Pharmaceuticals DJB, Inc. | NDA | View NDC → |
| 50 mg/mL | Intravenous | Xiromed, LLC | ANDA | View NDC → |
| 💊Nasal spray | ||||
| 5 mg/mL | Nasal | Apipharmausa, LLC × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 💊Other oral form | ||||
| 4.6 mg/4 g | Oral | Hanpoong Pharm Co.,ltd. | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 💊Tablet | ||||
| 25 mg | Oral | CVS Pharmacy, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 25 mg | Oral | CVS Pharmacy, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 12.5 mg | Oral | Foundation Consumer Brands | OTC MONOGRAPH DRUG | View NDC → |
| 12.5 mg | Oral | Foundation Consumer Brands | OTC MONOGRAPH FINAL | View NDC → |
| 25 mg | Oral | Foundation Consumer Healthcare LLC | OTC MONOGRAPH DRUG | View NDC → |
| 25 mg | Oral | Foundation Consumer Healthcare LLC | OTC MONOGRAPH FINAL | View NDC → |
| 5.34 mg/8 g | Oral | Hanpoong Pharm Co.,ltd. | OTC MONOGRAPH FINAL | Find on DailyMed ↗ |
| 12.5 mg | Oral | Walgreen Company | OTC MONOGRAPH DRUG | View NDC → |
| 12.5 mg | Oral | Walgreen Company | OTC MONOGRAPH FINAL | View NDC → |
| 25 mg | Oral | Walgreen Company | OTC MONOGRAPH DRUG | View NDC → |
| 25 mg | Oral | Walgreen Company | OTC MONOGRAPH FINAL | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Embio Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Malladi Drugs & Pharmaceuticals Limited × 5 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA × 2 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Siegfried PharmaChemikalien Minden GmbH × 2 listings | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
Showing 100 of 100 products — FDA National Drug Code Directory. See every product, package size and price: browse all 100 Ephedrine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ephedrine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ephedrine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Ephedrine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3966 8 dose forms · 19 strengths
-
Dose form (SCDF) Injectable Solution RxCUI 372022In current FDA listingsClinical drug / strength (SCD) hydrochloride 3 MG/MLRxCUI 1116196hydrochloride 30 MG/MLRxCUI 1116233sulfate 10 MG/MLRxCUI 1115981 -
Dose form (SCDF) Injection RxCUI 1734678In current FDA listingsClinical drug / strength (SCD) 1 ML ephedrine sulfate 50 MG/MLRxCUI 11162945 ML ephedrine hydrochloride 4.7 MG/MLRxCUI 256008510 ML ephedrine hydrochloride 4.7 MG/MLRxCUI 267167910 ML ephedrine sulfate 5 MG/MLRxCUI 2368456 -
Dose form (SCDF) Nasal Solution RxCUI 372019In current FDA listingsClinical drug / strength (SCD) hydrochloride 10 MG/MLRxCUI 1115985hydrochloride 5 MG/MLRxCUI 1116285 -
Dose form (SCDF) Nasal Spray RxCUI 374591In current FDA listingsClinical drug / strength (SCD) sulfate 2.5 MG/MLRxCUI 1116115 -
Dose form (SCDF) Oral Capsule RxCUI 372021No current FDA listingClinical drug / strength (SCD) sulfate 25 MGRxCUI 1116191 -
Dose form (SCDF) Oral Solution RxCUI 385759No current FDA listingClinical drug / strength (SCD) hydrochloride 0.8 MG/MLRxCUI 1115979hydrochloride 3 MG/MLRxCUI 1116160 -
Dose form (SCDF) Oral Tablet RxCUI 372020In current FDA listingsClinical drug / strength (SCD) hydrochloride 12.5 MGRxCUI 2534871hydrochloride 15 MGRxCUI 1115995hydrochloride 30 MGRxCUI 1116231sulfate 25 MGRxCUI 1116194 -
Dose form (SCDF) Prefilled Syringe RxCUI 727857No current FDA listingClinical drug / strength (SCD) 5 ML ephedrine sulfate 5 MG/MLRxCUI 258684110 ML ephedrine sulfate 5 MG/MLRxCUI 2631017
Look up RxCUI 3966 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Ephedrine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Ephedrine belongs to the alpha-Adrenergic Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 34 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Fresenius Kabi USA, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.